Company overview
Thermo Fisher Scientific provides end-to-end contract development and manufacturing organization (CDMO) services for pharmaceuticals, including APIs, biologics, viral vectors, cell and gene therapies, and small molecules from pre-clinical to commercialization. The company operates over 60 global sites with capabilities in sterile fill-finish, oral solid dose production, mRNA lipid nanoparticles, and clinical trial supply chain management. Recent expansions include Accelerator Drug Development solutions integrating CDMO, CRO, and logistics for biotech and large pharma.
Thermo Fisher Scientific - UK is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services, CDMO & Manufacturing partner serving United States & Americas. Core focus areas include thermo fisher scientific, pharma cdmo, biologics manufacturing, cell gene therapy, api production, clinical trial services.
Industry categories: CRO & Clinical Services, CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Thermo Fisher Scientific - UK include Cdmo — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://www.thermofisher.com/us/en/home.html
- Categories
- CRO & Clinical Services, CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- thermo fisher scientific, pharma cdmo, biologics manufacturing, cell gene therapy, api production, clinical trial services
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What manufacturing capabilities does Thermo Fisher offer for pharma?
- End-to-end CDMO services covering APIs, biologics, cell/gene therapies, sterile fill-finish in Italy and US, oral solid dose lines in US, Canada, France, plus mRNA and lipid nanoparticle production.
- What is the global reach of Thermo Fisher's pharma services?
- Over 60 sites worldwide, including expansions in Cincinnati (US), Toronto (Canada), Bourgoin (France), Ferentino/Monza (Italy), Plainville (US), with integrated global logistics and CRO capabilities.
- Does Thermo Fisher support regulatory compliance and clinical trials?
- Yes, provides cGMP-compliant manufacturing, clinical research patient enrollment via CRO, Accelerator Drug Development for pre-clinical to commercialization, and supply chain services meeting biopharma regulatory needs.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- IPEC Excipient World Biologics Summit 2026: Recap
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
